Deanna L. Kirkpatrick

Davis Polk advised the sole book runner in connection with the initial public offering of 30,000,000 units of East Resources Acquisition Company for aggregate proceeds of $300 million. Each…

Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 1.300% bonds due July 22, 2030, issued by the Province of Alberta. The…

Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by InflaRx N.V. of its shares of common stock for up to an aggregate amount of $50…

Davis Polk advised the representatives of the underwriters in connection with an initial public offering of Inventiva S.A.’s 7,478,261 American Depositary Shares. Aggregate gross…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $69 million follow-on offering of common stock of Magenta Therapeutics…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $650 million aggregate principal amount of 1.150% notes due 2028 and $650…

Davis Polk advised the underwriters in connection with the initial public offering of 51,750,000 units of Trebia Acquisition Corp., including 6,750,000 units purchased pursuant to the…

Davis Polk advised the representatives of the underwriters in connection with the $230 million initial public offering of 12,105,263 shares of common stock of Generation Bio Co., which…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $1.75 billion aggregate principal amount of its 0.750% senior notes due 2023 and (ii) $1 billion…

Davis Polk advised the placement agent in connection with a private placement pursuant to Rule 4(a)(2) by Humanigen Inc. of $72 million of common stock. Humanigen Inc. is a clinical…